An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.

Aims: We explored barriers and facilitators to the implementation of nonalcoholic fatty liver disease (NAFLD) pathway for people with diabetes to identify determinants of behaviour surrounding the diagnosis, assessment and management of NAFLD. Methods: Health practitioners (n = 24) recruited from mu...

Descripción completa

Detalles Bibliográficos
Publicado en:Diabetic Medicine Vol. 39; no. 6; pp. 1 - 15
Autores principales: Gracen, Lucy, Hayward, Kelly L., Aikebuse, Melanie, Williams, Suzanne, Russell, Anthony, O'Beirne, James, Powell, Elizabeth E., Valery, Patricia C.
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Jun2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156806479&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 156806479
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07423071
        F07
      jtl: Diabetic Medicine
      issn: 07423071
      maglogo: Y
    pubinfo:
      dt: Jun2022
      vid: 39
      iid: 6
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        156806479
        155074786
        156806479
        156806479
        10.1111/dme.14799
        156806479
      ppf: 1
      ppct: 14
      formats:
      tig:
        atl: An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
      aug:
        au:
          Gracen, Lucy
          Hayward, Kelly L.
          Aikebuse, Melanie
          Williams, Suzanne
          Russell, Anthony
          O'Beirne, James
          Powell, Elizabeth E.
          Valery, Patricia C.
        affil: Centre for Liver Disease Research, Faculty of Medicine, Translational Research Institute, The University of Queensland, Brisbane Queensland,, Australia
      sug:
        subj:
          Nonalcoholic Fatty Liver Disease Diagnosis
          Nonalcoholic Fatty Liver Disease Therapy
          Diabetes Mellitus, Type 2
          Primary Health Care
          Critical Path
          Attitude of Health Personnel
          Program Implementation
          Human
          Male
          Female
          Focus Groups
          Interviews
          Thematic Analysis
          Interview Guides
          Diabetic Patients
          Multidisciplinary Care Team
          Professional Knowledge
          Health Resource Allocation
          Risk Management
          Implementation Science
          Male
          Female
      ab: Aims: We explored barriers and facilitators to the implementation of nonalcoholic fatty liver disease (NAFLD) pathway for people with diabetes to identify determinants of behaviour surrounding the diagnosis, assessment and management of NAFLD. Methods: Health practitioners (n = 24) recruited from multidisciplinary diabetes clinics in primary care (n = 3) and hospital (n = 1) settings participated in four focus group discussions, and common themes were identified using thematic analysis. Results: Lack of knowledge and access to resources were key factors that underpinned an inconsistent approach by clinicians to NAFLD diagnosis and risk stratification and impacted their confidence to discuss the diagnosis with patients. Participants often prioritised other medical issues above NAFLD due to lack of concern about liver‐related consequences, reluctance to overburden patients with information, lack of time and perceived absence of accessible fibrosis tests. All participants agreed that implementation of a NAFLD pathway would improve patient care and the general practitioners proposed that screening for NAFLD could be incorporated into routine review cycles for type 2 diabetes. A consistent message from participants was that educating patients about their liver disease needs to be implemented in an integrated care pathway. Conclusions: From the perspectives of health practitioners, there is a gap in clinical practice for the implementation of clear, evidence‐based guidelines for NAFLD in people with T2D. By focusing on comorbidity prevention and integrating NAFLD as a diabetes complication to be addressed during established cycles of care, many barriers to implementing a NAFLD pathway in primary care could be overcome.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N